Long-term Safety and Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: the JUPITER Study

被引：0
|
作者：
Kawase, Kazuhide [1 ]
Vittitow, Jason L. [2 ]
Yamamoto, Tetsuya [1 ]
Araie, Makoto [3 ]
机构：
[1] Gifu Univ Hosp, Gifu, Japan
[2] Bausch Lomb, Clin Affairs, Bridgewater, NJ USA
[3] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Tokyo, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3037
引用
收藏
页数：2
相关论文
共 50 条
  • [31] LATANOPROSTENE BUNOD FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION: SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
    Royer, C.
    Beauchemin, C.
    Lachaine, J.
    Cui, A.
    Gervais, Jobin K.
    Barbeau, M.
    VALUE IN HEALTH, 2019, 22 : S363 - S363
  • [32] Long-term effect of canaloplasty on intraocular pressure and use of intraocular pressure-lowering medications in patients with open-angle glaucoma
    Ondrejka, Simon
    Koerber, Norbert
    Dhamdhere, Kavita
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2022, 48 (12): : 1388 - 1393
  • [33] Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
    Pozarowska, Dorota
    CLINICAL OPHTHALMOLOGY, 2010, 4 : 1229 - 1236
  • [34] Intraocular pressure lowering efficacy and safety of travoprost 0.004% as a replacement therapy in patients with open angle glaucoma or ocular hypertension
    Ge Jian
    Sun Xing-huai
    Wang Ning-li
    Zhao Jia-liang
    Wu Ling-ling
    Chen Xiao-ming
    Wang Zhi-xin
    Li, Benny
    CHINESE MEDICAL JOURNAL, 2010, 123 (11) : 1417 - 1421
  • [35] The long-term safety and efficacy of timolol maleate gel forming solution in patients with open-angle glaucoma or ocular hypertension
    Silver, LH
    Garadi, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S513 - S513
  • [36] A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
    Weinreb, Robert N.
    Ong, Tuyen
    Sforzolini, Baldo Scassellati
    Vittitow, Jason L.
    Singh, Kuldev
    Kaufman, Paul L.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (06) : 738 - 745
  • [37] Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension
    Katz, L. Jay
    Simmons, Steven T.
    Craven, E. Randy
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (12) : 2971 - 2983
  • [38] Latanoprostene Bunod 0.024% w/v Treatment of Open-anlge Glaucoma: Short-term Effects, Safety, and Changes in Ocular Blood Flow
    Kim, Hyun Woo
    Lee, Chong Eun
    Seo, Sam
    Lee, Kyoo Won
    Lee, Chang Hoon
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2023, 64 (10): : 930 - 938
  • [39] Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Berdahl, John P.
    Sarkisian, Steven R.
    Ang, Robert E.
    Doan, Long V.
    Kothe, Angela C.
    Usner, Dale W.
    Katz, L. Jay
    Navratil, Tomas
    DRUGS, 2024, 84 (01) : 83 - 97
  • [40] Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
    John P. Berdahl
    Steven R. Sarkisian
    Robert E. Ang
    Long V. Doan
    Angela C. Kothe
    Dale W. Usner
    L. Jay Katz
    Tomas Navratil
    Drugs, 2024, 84 : 83 - 97
12345